CRISPR gene-edited cell therapy improves quality of life in patients with transfusion-dependent beta-thalassemia, research suggests.

According to the DataM Intelligence, The global cancer gene therapy market size was valued as US$ 3.97 billion in 2024 and is ...

CHINO HILLS, CALIFORNIA / ACCESS Newswire / September 15, 2025 / SOHM, Inc. (OTCID:SHMN), a pharmaceutical and biotechnology company specializing in generic drugs and gene-editing tools, a leader in ...

Hybrid seed production is vital for enhancing crop yield and quality, yet conventional methods in rapeseed are limited by inefficiency and high ...

By leveraging the Protein Mutation Effect Predictor (ProMEP), AI-AncBE4max, a high-performance Cas9 variant with eight ...

Researchers engineered a CRISPR base editor to correct the ACTA2 mutation causing multisystemic smooth muscle dysfunction ...

Maria Jasin, PhD, whose research on DNA repair has transformed our understanding of cancers, has been selected as the 2025 recipient of the Greengard Prize.

Dr Daniel Hershtain, CEO of the Israel National Anti-Doping Agency, has teamed up with leaders in genetic research, ...

Xenotransplantation, leveraging genetic engineering and CRISPR, offers a promising solution to the organ shortage crisis ...

Oral presentation highlights significant reduction in HBV DNA integration and other clinically-relevant biomarkers from the EBT-107 therapeutic ...

When Cathie Wood’s ARK Invest adds stocks to its portfolio, it tends to catch attention. Wood is not your typical Wall Street ...

In recent decades, sensor-less cars that rely on human decision-making have evolved into self-driving taxis that arrive on demand. Beate Mueller-Tiemann, PhD, CTO of the global CDMO Cytiva, points to ...